A high-throughput bone marrow 3D co-culture system to study resistance to BCR signalling targeted agents in B-NHL.

Saved in:
Bibliographic Details
Title: A high-throughput bone marrow 3D co-culture system to study resistance to BCR signalling targeted agents in B-NHL.
Authors: Zadro A; Regenerative Medicine Division, Institute for Translational Research, Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Arribas A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Colombo MV; Regenerative Medicine Division, Institute for Translational Research, Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Mensah AA; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Simonetta F; Division of Hematology, Department of Oncology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.; Translational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Petta D; Regenerative Medicine Division, Institute for Translational Research, Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Candrian C; Service of Orthopedics and Traumatology, Department of Surgery, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.; Euler Institute, Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Arrigoni C; Regenerative Medicine Division, Institute for Translational Research, Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Euler Institute, Faculty of Biomedical Sciences, USI, Lugano, Switzerland., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Moretti M; Regenerative Medicine Division, Institute for Translational Research, Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI)-Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Euler Institute, Faculty of Biomedical Sciences, USI, Lugano, Switzerland.; IRCCS Istituto Ortopedico Galeazzi, Cell and Tissue Engineering Laboratory, Milan, Italy.
Source: British journal of haematology [Br J Haematol] 2026 Feb; Vol. 208 (2), pp. 716-721. Date of Electronic Publication: 2025 Dec 08.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2141
DOI:10.1111/bjh.70273